Skip to content
Filings

GXO Logistics GXO Form 10-Q filing Q1 FY2026

Filed
May 6, 2026, 4:20 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001852244-26-000014

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements (Unaudited)

ITEM 1. FINANCIAL STATEMENTS

Condensed Consolidated Statements of Operations

Unaudited

View SEC source
(Dollars in millions, shares in thousands, except per share amounts)Three Months Ended March 31, 20262025
Revenue
Direct operating expense
Selling, general and administrative expense
Depreciation and amortization expense
Transaction and integration costs
Restructuring costs and other
Regulatory matter
Net loss on divestiture of business
Operating income (loss)()
Other income (expense), net()
Interest expense, net()()
Income (loss) before income taxes()
Income tax expense()()
Net income (loss)()
Net income attributable to noncontrolling interests (“NCI”)()()
Net income (loss) attributable to GXO$()
Earnings (loss) per share
Basic$()
Diluted$()
Weighted-average shares outstanding used in computation of earnings (loss) per share
Basic
Diluted

See accompanying Notes to Condensed Consolidated Financial Statements.

Condensed Consolidated Statements of Comprehensive Loss

Unaudited

View SEC source
(In millions)Three Months Ended March 31, 20262025
Net income (loss)$()
Other comprehensive income (loss), net of tax
Foreign currency translation adjustments()
Cash flow hedges()
Fair value hedges1
Pension plans()
Other comprehensive income (loss), net of tax()
Comprehensive loss, net of tax()()
Less: Comprehensive income attributable to NCI
Comprehensive loss attributable to GXO$()$()

See accompanying Notes to Condensed Consolidated Financial Statements.

Condensed Consolidated Balance Sheets

Unaudited

View SEC source
(Dollars in millions, shares in thousands, except per share amounts)March 31, 2026December 31, 2025
ASSETS
Current assets
Cash and cash equivalents
Accounts receivable, net of allowance of and
Other current assets
Total current assets
Long-term assets
Property and equipment, net of accumulated depreciation of and
Operating lease assets
Goodwill
Intangible assets, net of accumulated amortization of and
Other long-term assets
Total long-term assets
Total assets
LIABILITIES AND EQUITY
Current liabilities
Accounts payable
Accrued expenses
Current debt
Current operating lease liabilities
Other current liabilities
Total current liabilities
Long-term liabilities
Long-term debt
Long-term operating lease liabilities
Other long-term liabilities
Total long-term liabilities
Commitments and Contingencies (Note 14)
Stockholders’ Equity
Common Stock, par value per share; shares authorized, and shares issued and and shares outstanding, respectively
Treasury stock, at cost; and shares, respectively()()
Preferred Stock, par value per share; shares authorized, issued and outstanding
Additional Paid-In Capital (“APIC”)
Retained earnings
Accumulated Other Comprehensive Income (Loss) (“AOCIL”)()()
Total stockholders’ equity before NCI
NCI
Total equity
Total liabilities and equity

See accompanying Notes to Condensed Consolidated Financial Statements.

Condensed Consolidated Statements of Cash Flows

Unaudited

View SEC source
(In millions)Three Months Ended March 31, 2026Three Months Ended March 31, 2025
Cash flows from operating activities:
Net income (loss)$()
Adjustments to reconcile net income (loss) to net cash provided by operating activities
Depreciation and amortization expense
Stock-based compensation expense
Deferred tax benefit()()
Other
Changes in operating assets and liabilities
Accounts receivable()()
Other assets()
Accounts payable()()
Accrued expenses and other liabilities()
Net cash provided by operating activities
Cash flows from investing activities:
Capital expenditures()()
Proceeds from sale of property and equipment
Net cash used in investing activities()()
Cash flows from financing activities:
Common stock repurchased()
Net borrowings under revolving credit facilities
Repayments of finance lease obligations(14)(11)
Proceeds from exercise of stock options
Taxes paid related to net share settlement of equity awards()()
Other()
Net cash used in financing activities()()
Effect of exchange rates on cash and cash equivalents(3)11
Net decrease in cash, restricted cash and cash equivalents()()
Cash, restricted cash and cash equivalents, beginning of period
Cash, restricted cash and cash equivalents, end of period
Non-cash financing activities:
Unsettled stock repurchases for which trades occurred$4
Excise tax liability related to stock repurchases1
Reconciliation of cash, restricted cash and cash equivalentsMarch 31, 2026December 31, 2025
Cash and cash equivalents
Restricted Cash (included in Other current assets)
Restricted Cash (included in Other long-term assets)
Total cash, restricted cash and cash equivalents

See accompanying Notes to Condensed Consolidated Financial Statements.

Condensed Consolidated Statements of Changes in Equity

Unaudited

View SEC source
(Shares in thousands,dollars in millions)Common StockSharesCommon StockAmountCommon StockTreasury StockAPICRetained EarningsAOCILEquity Before NCINCITotal Equity
Balance as of December 31, 2025114,512$1$(202)$2,667$718$(201)$2,983$32
Net income441
Other comprehensive income (loss)(21)(21)2()
Common stock issued under employee stock plans and exercises of stock options78777
Tax withholding on vesting of stock-based compensation awards(275)(15)(15)()
Stock-based compensation1010
Balance as of March 31, 2026115,024$1$(202)$2,669$722$(222)$2,968$35
(Shares in thousands,dollars in millions)Common StockSharesCommon StockAmountCommon StockTreasury StockAPICRetained EarningsAOCILEquity Before NCINCITotal Equity
Balance as of December 31, 2024119,496$1$2,629$686$(313)$3,003$32
Net income (loss)(96)(96)1()
Other comprehensive income68681
Common stock issued under employee stock plans and exercises of stock options370
Tax withholding on vesting of stock-based compensation awards(145)(6)(6)()
Stock-based compensation1212
Common stock repurchased(2,766)(111)(111)()
Balance as of March 31, 2025116,955$1$(111)$2,635$590$(245)$2,870$34

See accompanying Notes to Condensed Consolidated Financial Statements.

GXO Logistics, Inc.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

  1. Basis of Presentation and Significant Accounting Policies and Estimates

Basis of Presentation

The accompanying unaudited Condensed Consolidated Financial Statements of GXO Logistics, Inc. (“GXO” or the “Company”) have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and pursuant to the rules of the United States Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included.

Operating results for the interim periods are not necessarily indicative of the results that may be expected for the year ending December 31, 2026. The Company’s Condensed Consolidated Financial Statements include the accounts of GXO and its majority-owned subsidiaries and variable interest entities of which the Company is the primary beneficiary. The Company has eliminated intercompany accounts and transactions. The accompanying Condensed Consolidated Financial Statements and Notes thereto should be read in conjunction with the Annual Report on Form 10-K for the year ended December 31, 2025.

The Company presents its operations as reportable segment.

Accounting Pronouncements Issued But Not Yet Adopted

In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. This standard requires all public companies to disclose more detailed information about certain costs and expenses in the notes to the financial statements at interim and annual reporting periods. This standard is effective for annual reporting periods beginning after December 15, 2026, with early adoption permitted. The Company does not expect this standard to have a material impact on its results of operations, financial position or cash flows, and is currently evaluating the impact of adopting this standard on its disclosures.

In September 2025, the FASB issued ASU 2025-06, Intangibles- Goodwill and Other- Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. The amendments in this update remove all references to prescriptive and sequential software development stages (referred to as “project stages”) throughout Subtopic 350-40. Therefore, an entity is required to start capitalizing software costs when certain capitalization criteria are met. The ASU also supersedes guidance on website development costs. The amendments are effective for all entities for annual reporting periods beginning after December 15, 2027, and interim reporting periods within those annual reporting periods. Early adoption is permitted as of the beginning of an annual reporting period. The Company is currently evaluating the impact of this standard on its results of operations, financial position or cash flows, and the impact of adopting this standard on its disclosures.

  1. Revenue Recognition

Revenue disaggregated by geographical area was as follows:

(In millions)Three Months Ended March 31, 20262025
United Kingdom
United States
Netherlands
France
Spain
Italy
Other
Total

The Company’s revenue can also be disaggregated by various verticals, reflecting the customers’ principal industry. Revenue disaggregated by industry was as follows:

(In millions)Three Months Ended March 31, 20262025
Omnichannel retail
Technology and consumer electronics
Industrial and manufacturing
Consumer packaged goods
Food and beverage
Other
Total

Contract Assets and Liabilities

The contract asset and contract liability balances from contracts with customers were as follows:

(In millions)March 31, 2026December 31, 2025
Contract assets and contract costs included in:
Other current assets
Other long-term assets
Total contract assets
Contract liabilities included in:
Other current liabilities
Other long-term liabilities
Total contract liabilities

Revenue recognized included the following:

(In millions)Three Months Ended March 31, 20262025
Amounts included in the beginning of year contract liability balance$212$197
  1. Segment Information

The Company is organized geographically into operating segments: i) Americas and Asia-Pacific, ii) United Kingdom and Ireland, and iii) Continental Europe. The Company’s reporting unit results are regularly provided to the Chief Operating Decision Maker (“CODM”). The CODM is our Chief Executive Officer, who assesses the Company’s performance and allocates resources.

The CODM evaluates the Company’s performance and allocates resources primarily based on adjusted earnings before interest, taxes, depreciation and amortization, adjusted for transaction and integration costs, restructuring costs and other, regulatory matter, net loss on divestiture of business and unrealized gain/loss on foreign currency contracts (“Adjusted EBITDA”). The CODM uses Adjusted EBITDA to communicate performance targets to the segment managers, allocate resources to the segments, and to monitor segment performance. Additionally, the CODM considers the performance of this measure against planned and forecasted amounts to make investing and resource allocation decisions. The actual results are used in assessing performance of the Company and in establishing management’s compensation.

For disclosure purposes, we aggregate these operating segments into reportable segment due to the similar nature of their operations and economic characteristics.

The Company’s segment results were as follows:

(In millions)Three Months Ended March 31, 20262025
Revenue
Direct operating expense
Selling, general and administrative expense(1)
Other income, net(2)(3)()()
Segment Adjusted EBITDA
Less:
Corporate expenses(4)
Depreciation expense
Amortization of intangible assets acquired
Transaction and integration costs
Restructuring costs and other
Regulatory matter
Net loss on divestiture of business
Unrealized (gain) loss on foreign currency contracts(3)()
Interest expense, net
Income (loss) before income taxes()
Income tax expense()()
Net income (loss)$()

(1) Excludes unallocated corporate expenses.

(2) Other income (expense), net, excluding unrealized (gain) loss on foreign currency contracts.

(3) Included in Other income (expense), net in the Condensed Consolidated Statements of Operations.

(4) Corporate expenses include unallocated costs related to corporate functions such as salaries and benefits, rent, and professional fees which are recorded in Selling, general and administrative expenses in the Condensed Consolidated Statements of Operations.

  1. Leases

The Company has entered into noncancelable operating and finance leases primarily for real estate and warehouse equipment. The Company determines whether an arrangement is a lease at inception and, if so, whether that lease meets the classification criteria for a finance or an operating lease at the commencement date.

Total lease cost recorded in the Condensed Consolidated Statements of Operations was as follows:

(In millions)Three Months Ended March 31, 20262025
Operating lease cost(1)(2)$212$206
Finance lease cost:
Amortization of the right-of-use assets(3)107
Interest on the lease liabilities(4)44
Total finance lease cost1411
Variable lease cost(1)
Short-term lease cost(1)4747
Total lease cost(5)

(1) Operating, variable, and short-term lease costs are primarily included in Direct operating expense in the Condensed Consolidated Statements of Operations.

(2) For the three months ended March 31, 2026, the Company recorded a net benefit of million from a real estate transaction that resulted in an early termination of a lease.

(3) Amortization of right-of-use assets is included in Depreciation and amortization in the Condensed Consolidated Statements of Operations.

(4) Interest on the lease liabilities is included in Interest expense, net in the Condensed Consolidated Statements of Operations.

(5) Total lease cost excludes sublease income for all periods presented, as it was not material.

The following amounts were recorded in the Condensed Consolidated Balance Sheets related to leases:

(In millions)March 31, 2026December 31, 2025
Operating leases:
Operating lease assets
Current operating lease liabilities
Long-term operating lease liabilities
Total operating lease liabilities
Finance leases:
Property and equipment, net
Current debt
Long-term debt
Total finance lease liabilities

Subsequent to the quarter end, the Company entered into a finance lease in the amount of $89 million with a commencement date of April 1, 2026.

Supplemental cash flow information related to leases was as follows:

(In millions)Right-of-use assets obtained in exchange for lease liabilities:Three Months Ended March 31, 2026Three Months Ended March 31, 2025
Operating leases
Finance leases
  1. Goodwill

The following table presents the changes in Goodwill for the three months ended March 31, 2026:

(In millions)
Balance as of December 31, 2025
Impact of foreign exchange translation()
Balance as of March 31, 2026

As of March 31, 2026 and December 31, 2025, there was a million accumulated goodwill impairment loss.

  1. Intangible Assets

The following table summarizes identifiable intangible assets subject to amortization:

(In millions)March 31, 2026Gross Carrying AmountMarch 31, 2026Accumulated AmortizationMarch 31, 2026Net ValueDecember 31, 2025Gross Carrying AmountDecember 31, 2025Accumulated AmortizationDecember 31, 2025Net Value
Customer relationships$1,564$(742)$822$1,609$(747)$862
Trade names and trademarks64(32)3264(29)35
Developed technology17(6)1117(5)12
Total$()$()

Intangible asset amortization expense was million and million for the three months ended March 31, 2026 and 2025, respectively.

  1. Debt and Financing Arrangements

The following table summarizes the carrying value of the Company’s debt:

(In millions, except percentages)Rate(1)March 31, 2026December 31, 2025
Unsecured notes due 20261.65%$400$400
Unsecured notes due 2029(2)6.25%595594
Unsecured notes due 2031(3)2.65%398398
Unsecured notes due 2034(4)6.50%491491
Euro unsecured notes due 2030 (€500 principal)(5)3.75%571580
Five-Year Term Loan due 20275.14%275275
Finance leases and other debtVarious379327
Total Debt
Less: Current debt(6)
Total Long-term debt

(1) Interest rate as of March 31, 2026.

(2) Net of unamortized discount and debt issuance costs of $5 million and $6 million as of March 31, 2026 and December 31, 2025, respectively.

(3) Net of unamortized discount and debt issuance costs of $2 million as of March 31, 2026 and December 31, 2025.

(4) Net of unamortized discount and debt issuance costs of $9 million as of March 31, 2026 and December 31, 2025.

(5) Net of unamortized discount and debt issuance costs of $7 million as of March 31, 2026 and December 31, 2025.

(6) As of March 31, 2026, and December 31, 2025, current debt includes $400 million of Unsecured notes due July 2026.

Revolving Credit Facilities

The Company has a five-year unsecured, multicurrency revolving credit facility expiring in 2029 (the “Revolving Credit Agreement”). The aggregate commitment of all lenders under the Revolving Credit Agreement is equal to $800 million, of which $100 million is available for the issuance of letters of credit. As of March 31, 2026, and December 31, 2025, no amounts were outstanding, and letters of credit were million and million, respectively, under the Revolving Credit Agreement.

Borrowings under revolving credit facilities maturing in three months or less are presented net in the Condensed Consolidated Statement of Cash Flows.

Covenants and Compliance

The covenants for the Company’s debt securities, which are customary for financings of this type, limit the Company’s ability to incur indebtedness and grant liens, among other restrictions. In addition, the facilities require the Company to maintain a consolidated leverage ratio below a specified maximum. As of March 31, 2026, the Company complied with the covenants contained in its debt and financing arrangements.

Factoring Programs

The Company sells certain of its trade receivables on a non-recourse basis to third-party financial institutions under various factoring agreements.

Information related to the trade receivables sold was as follows:

(In millions)Three Months Ended March 31, 20262025
Receivables sold in period$601$602
Cash consideration
Net cash provided by (used in) operating cash flows()
  1. Fair Value Measurements and Financial Instruments

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The levels of inputs used to measure fair value are:

  • Level 1—Quoted prices for identical instruments in active markets;
  • Level 2—Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets; and
  • Level 3—Valuations based on inputs that are unobservable, generally utilizing pricing models or other valuation techniques that reflect management’s judgment and estimates.

Assets and Liabilities

The Company bases its fair value estimates on market assumptions and available information. The carrying values of cash and cash equivalents, accounts receivable, accounts payable, accrued expenses and current maturities of long-term debt approximated their fair values as of March 31, 2026 and December 31, 2025, due to their short-term nature.

Debt

The fair value of debt was as follows:

(In millions)LevelMarch 31, 2026Fair ValueMarch 31, 2026Carrying ValueDecember 31, 2025Fair ValueDecember 31, 2025Carrying Value
Unsecured notes due 20262$397$400$394$400
Unsecured notes due 20292622595631594
Unsecured notes due 20312356398358398
Unsecured notes due 20342525491540491
Euro unsecured notes due 20302567571586580
Five-Year Term Loan due 20272272275272275

Financial Instruments

The Company directly manages its exposure to risks arising from business operations and economic factors, including fluctuations in interest rates and foreign currencies. The Company uses derivative instruments to manage the volatility related to these exposures.

The notional amount and fair value of derivative instruments were as follows:

(In millions)March 31, 2026Notional AmountMarch 31, 2026Fair ValueDecember 31, 2025Notional AmountDecember 31, 2025Fair ValueBalance Sheet Location
Derivatives designated as net investment hedges:
Cross-currency swaps$422$26$422$33Other current liabilities
Cross-currency swaps1,4001111,400143Other long-term liabilities
Derivatives designated as fair value hedges:
Cross-currency swaps$236$5Other long-term assets
Cross-currency swaps2361Other long-term liabilities
Derivatives not designated as hedges:
Foreign currency option contracts$267$5$308$3Other current assets
Foreign currency option contracts27423164Other current liabilities
Foreign currency forward contracts3Other current assets
Foreign currency forward contracts1392311Other current liabilities

As of March 31, 2026 and December 31, 2025, the derivatives were classified as Level 2 within the fair value hierarchy. The derivatives are valued using inputs other than quoted prices such as foreign exchange rates and yield curves.

The effect of hedges on AOCIL and in the Condensed Consolidated Statements of Operations was as follows:

(In millions)Three Months Ended March 31, 2026Amount of Gain (Loss) Recognized in Other Comprehensive Income on DerivativeThree Months Ended March 31, 2026Gain (Loss) Reclassified from AOCIL into Net IncomeThree Months Ended March 31, 2026Gain (Loss) Recognized in Net Income on Derivative (Excluded from effectiveness testing)Three Months Ended March 31, 2025Amount of Gain (Loss) Recognized in Other Comprehensive Income on DerivativeThree Months Ended March 31, 2025Gain (Loss) Reclassified from AOCIL into Net IncomeThree Months Ended March 31, 2025Gain (Loss) Recognized in Net Income on Derivative (Excluded from effectiveness testing)
Net investment hedges
Cross-currency swaps(1)$39$(1)$1$(76)$(3)$1
Cash flow hedges
Interest rate swaps(1)$(1)
Fair value hedges
Cross-currency swaps(2)$2$1

(1) Amounts reclassified to Net income are reported in Interest expense, net in the Condensed Consolidated Statements of Operations.

(2) Amounts reclassified to Net income are reported in Other income, net in the Condensed Consolidated Statements of Operations.

Derivatives Not Designated as Hedges

Gains and losses recognized in Other income (expense), net in the Condensed Consolidated Statements of Operations for foreign currency options and forward contracts were as follows:

(In millions)Three Months Ended March 31, 20262025
Foreign currency gain (loss) on foreign currency contracts$3$(8)
  1. Restructuring Costs and Other

Restructuring costs and other primarily consisted of severance paid to exiting members of the Company’s leadership team and to individuals as part of an initiative to optimize corporate expenses.

The following table summarizes changes in the restructuring liability, which is included in Accrued expenses and Other long-term liabilities in the Condensed Consolidated Balance Sheets.

(In millions)SeveranceSeverance
Balance as of December 31, 2025$15
Charges incurred3
Payments(4)
Balance as of March 31, 2026$14

As of March 31, 2026, $10 million of the restructuring liability is expected to be paid in the next 12 months.

  1. Divestiture

In 2024, the Company completed the acquisition of Wincanton plc (now Wincanton Limited) (the “Wincanton Acquisition”). The Wincanton Acquisition was subject to review by the U.K. Competition and Markets Authority (the “CMA”). In 2025, the CMA approved the Wincanton Acquisition, subject to the divestment of certain grocery contracts in the U.K. (the “Wincanton Divestment”).

In the fourth quarter of 2025, the Company met the held-for-sale criteria for the anticipated Wincanton Divestment and recorded a $37 million write-down loss, including $4 million of goodwill, $21 million of customer relationships, and $12 million fair value adjustment. In the first quarter of 2026, the Company recorded an additional $21 million impairment due to a further reduction in estimated fair value.

Assets and liabilities held for sale were not material as of March 31, 2026, and December 31, 2025, and are included in Other current assets and Other current liabilities, respectively, in the Condensed Consolidated Balance Sheets. The Company expects to complete the Wincanton Divestment before the end of the year.

  1. Employee Benefit Plans

Defined Benefit Plans

The Company offers pension plans in certain jurisdictions, with the most significant in the U.K. In the U.K., the Company sponsors two defined benefit pension schemes (the “U.K. Retirement Plans”). The U.K. Retirement Plans do not allow for new plan participants or additional benefit accruals. The funded status of the U.K. Retirement Plans was recorded in Other long-term assets in the Condensed Consolidated Balance Sheets.

The Company considers its other defined benefit pension plans not material to its Consolidated Financial Statements and excludes them from the disclosure below.

Components of the net periodic benefit income recognized under the U.K. Retirement Plans were as follows:

(In millions)Three Months Ended March 31, 20262025
Interest cost$(20)$(21)
Expected return on plan assets2927
Amortization of net loss(2)(1)
Net periodic pension income(1)$7$5

(1) Net periodic pension income was recorded in Other income (expense), net in the Condensed Consolidated Statements of Operations.

Defined Contribution Plans

Also, the Company has defined-contribution retirement plans for its United States employees and employees of certain foreign subsidiaries. In these plans, employees are allowed to contribute a portion of their salaries and bonuses to the plans, and the Company matches a portion of the employee contributions.

Defined contribution plan costs were as follows:

(In millions)Three Months Ended March 31, 20262025
Defined contribution costs(1)

(1) Defined contribution plan costs were primarily recorded in Direct operating expense in the Condensed Consolidated Statements of Operations.

  1. Income Taxes

Income tax expense for the three months ended March 31, 2026, was million compared with million for the same period in 2025. The Company’s effective tax rate for the three months ended March 31, 2026, was an expense on a pre-tax income of %, compared to an expense on a pre-tax loss of ()% for the same period in 2025. The change to the Company’s effective tax rate was primarily driven by an increase in pre-tax income, as well as an increase in unrecognized tax benefits, and a non-deductible fair value adjustment related to the Wincanton Divestment in the current period, and the regulatory matter in the prior period.

  1. Stockholders’ Equity

Stock Repurchase Plan

In February 2025, the Company’s board of directors authorized and announced the repurchase of up to million of its common stock (the “Repurchase Plan”). The Repurchase Plan permits shares of common stock to be repurchased from time to time in management’s discretion. The Repurchase Plan does not obligate the Company to repurchase any specific number of shares of common stock and may be suspended or discontinued at any time. shares were repurchased during the first quarter of 2026. As of December 31, 2025, and March 31, 2026, the remaining authorization under the Repurchase Plan was million.

Accumulated Other Comprehensive Income - Loss

The following tables summarize the changes in AOCIL by component:

(In millions)Foreign Currency AdjustmentForeign Currency Translation AdjustmentsForeign Currency AdjustmentNet Investment HedgesCash Flow HedgesFair Value HedgesDefined Benefit PlansLess: AOCILattributable to NCIAOCILattributableto GXO
As of December 31, 2025$147$(164)$1$(1)$(186)$2$(201)
Other comprehensive income (loss) before reclassifications(54)3923(2)(12)
Amounts reclassified to net income(1)21
Tax amounts(1)(8)(1)(10)
Other comprehensive income (loss), net of tax(55)3114(2)(21)
As of March 31, 2026$92$(133)$1$(182)$(222)
(In millions)Foreign Currency AdjustmentForeign Currency Translation AdjustmentsForeign Currency AdjustmentNet Investment HedgesCash Flow HedgesDefined Benefit PlansLess: AOCILattributable to NCIAOCILattributableto GXO
As of December 31, 2024$(195)$31$4$(155)$2$(313)
Other comprehensive income (loss) before reclassifications131(76)(1)(6)(1)47
Amounts reclassified to net income213
Tax amounts17118
Other comprehensive income (loss), net of tax131(57)(1)(4)(1)68
As of March 31, 2025$(64)$(26)$3$(159)$1$(245)
  1. Commitments and Contingencies

The Company is involved, and will continue to be involved, in numerous legal proceedings arising from the conduct of its business. These proceedings may include personal injury claims arising from the transportation and handling of goods, contractual disputes and employment-related claims, including alleged violations of wage and hour laws.

The Company establishes accruals for specific legal proceedings when it is considered probable that a loss has been incurred and the amount of the loss can be reasonably estimated. The Company reviews and adjusts accruals for loss contingencies quarterly and as additional information becomes available. If a loss is not both probable and reasonably estimable, or if an exposure to a loss exists in excess of the amount accrued, the Company assesses whether there is at least a reasonable possibility that a loss, or additional loss, may have been incurred. If there is a reasonable possibility that a loss, or additional loss, may have been incurred, the Company discloses the estimate of the possible loss or range of loss if it is material and an estimate can be made, or discloses that such an estimate cannot be made. The determination as to whether a loss can reasonably be considered to be possible or probable is based on management’s assessment, together with legal counsel, regarding the ultimate outcome of the matter.

Management of the Company believes that it has adequately accrued for the potential impact of loss contingencies that are probable and reasonably estimable. Management of the Company does not believe that the ultimate resolution of any matters to which the Company is presently a party will have a material adverse effect on its results of operations, financial condition or cash flows. However, the results of these matters cannot be predicted with certainty, and an unfavorable resolution of one or more of these matters could have a material adverse effect on the Company’s financial condition, results of operations or cash flows. Legal costs related to these matters are expensed as they are incurred.

The Company carries liability and excess umbrella insurance policies that are deemed sufficient to cover potential legal claims arising in the normal course of conducting its operations. In the event the Company is required to satisfy a legal claim outside the scope of the coverage provided by insurance, its financial condition, results of operations or cash flows could be negatively impacted.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Results of Operations

Three Months Ended March 31, 2026 compared with the Three Months Ended March 31, 2025

(In millions, except percentages)Three Months Ended March 31, 2026Three Months Ended March 31, 2025Three Months Ended March 31,$ ChangeThree Months Ended March 31,% Change
Revenue$3,298$2,977$32111%
Direct operating expense2,8082,55825010%
Selling, general and administrative expense2962613513%
Depreciation and amortization expense11510966%
Transaction and integration costs1622(6)(27)%
Restructuring costs and other317(14)(82)%
Regulatory matter66(66)(100)%
Net loss on divestiture of business2121n/m
Operating income (loss)39(56)95n/m
Other income (expense), net10(5)15n/m
Interest expense, net(32)(32)
Income (loss) before income taxes17(93)110n/m
Income tax expense(12)(2)(10)n/m
Net income (loss)$5$(95)$100n/m

n/m - not meaningful

Revenue for the three months ended March 31, 2026, increased by 11%, or $321 million, to $3.3 billion compared with $3.0 billion for the same period in 2025. The increase reflects growth in our business and $198 million of foreign currency movements for the three months ended March 31, 2026.

Direct operating expense for the three months ended March 31, 2026, increased by 10%, or $250 million, to $2.8 billion compared with $2.6 billion for the same period in 2025. As a percentage of revenue, Direct operating expense for the three months ended March 31, 2026, decreased to 85.1% compared with 85.9% for the same period in 2025. The increase reflects growth in our business and $158 million of foreign currency movements for the three months ended March 31, 2026. For the three months ended March 31, 2026, we recorded a net benefit of $28 million, primarily in rent expense, from a real estate transaction that resulted in an early termination of a lease. The increase in Direct operating expense before recognizing the real estate transaction was in line with our business growth.

Selling, general and administrative expense (“SG&A”) for the three months ended March 31, 2026, increased by $35 million, to $296 million compared with $261 million for the same period in 2025. The increase reflects growth in our business and $19 million of foreign currency movements for the three months ended March 31, 2026.

Depreciation and amortization expense for the three months ended March 31, 2026, increased by $6 million, to $115 million, compared with $109 million for the same period in 2025. Amortization expense was $29 million for both the three months ended March 31, 2026, and 2025.

Transaction and integration costs for the three months ended March 31, 2026, and 2025, were $16 million and $22 million, respectively, and primarily related to the acquisition and integration of Wincanton plc (now Wincanton Limited).

Restructuring costs and other costs for the three months ended March 31, 2026, and 2025, were $3 million and $17 million, respectively. Restructuring costs primarily consisted of severance paid to exiting members of the Company’s leadership team and to individuals as part of an initiative to optimize corporate expenses.

Regulatory matter for the three months ended March 31, 2025, was $66 million and related to the deductibility of value-added tax payments we made to certain third-party service providers, which was settled in 2025.

Net loss on divestiture of business for the three months ended March 31, 2026, was $21 million, and related to a further reduction of the estimated fair value of certain grocery contracts. See Note 10. “Divestiture,” to the Condensed Consolidated Financial Statements.

Other income (expense), net increased from expense to income, primarily due to foreign currency gain on foreign currency contracts. Other income (expense), net was as follows:

(In millions, except percentages)Three Months Ended March 31, 2026Three Months Ended March 31, 2025Three Months Ended March 31,$ ChangeThree Months Ended March 31,% Change
Net periodic pension income$7$5$240%
Foreign currency gain (loss):
Realized loss on foreign currency contracts(1)(1)n/m
Unrealized gain (loss) on foreign currency contracts4(10)14n/m
Foreign currency transaction and remeasurement gain, net of foreign currency contracts on intercompany loans11n/m
Total foreign currency gain (loss)4(10)14n/m
Other(1)(1)n/m
Other income (expense), net$10$(5)$15n/m

n/m - not meaningful

Interest expense, net was as follows:

(In millions, except percentages)Three Months Ended March 31, 2026Three Months Ended March 31, 2025Three Months Ended March 31,$ ChangeThree Months Ended March 31,% Change
Debt and capital leases$43$43
Cross-currency swaps(8)(9)1(11)%
Interest income(3)(2)(1)50%
Interest expense, net$32$32

Income (loss) before income taxes for the three months ended March 31, 2026, was income of $17 million compared with a loss of $93 million for the same period in 2025. The increase from loss to income reflects higher operating income, primarily due to growth in our business and a net benefit of $28 million from a real estate transaction, lower regulatory matters, and unrealized gain on foreign currency contracts.

Income tax expense for the three months ended March 31, 2026, was $12 million compared with $2 million for the same period in 2025. Our effective tax rate for the three months ended March 31, 2026, was an expense on a pre-tax income of 68.9%, compared to an expense on a pre-tax loss of (2.7)% for the same period in 2025. The change to our effective tax rate was primarily driven by an increase in pre-tax income, as well as an increase in unrecognized tax benefits, and a non-deductible fair value adjustment related to the Wincanton Divestment in the current period, and the regulatory matter in the prior period.

Liquidity and Capital Resources

Our ability to fund our operations and anticipated capital needs is reliant upon the generation of cash from operations, supplemented as necessary by periodic utilization of our revolving credit facility and factoring programs. Our principal uses of cash in the future will be primarily to fund our operations, working capital needs, capital expenditures, repayment of borrowings and strategic business development transactions. The timing and magnitude of our new contract start-ups can vary and may positively or negatively impact our cash flows. We continually evaluate our liquidity requirements and capital structure in light of our operating needs, growth initiatives and capital resources.

As of March 31, 2026, we held cash and cash equivalents of $794 million and restricted cash of $3 million, and we had $793 million of borrowing capacity, net of letters of credit under our revolving credit facility.

In February 2025, our board of directors authorized and announced the repurchase of up to $500 million of our common stock (the “Repurchase Plan”). The Repurchase Plan permits shares of common stock to be repurchased from time to time in management’s discretion. The Repurchase Plan does not obligate the Company to repurchase any specific number of shares of common stock and may be suspended or discontinued at any time. We expect to fund any remaining repurchases with existing cash on hand, borrowings on our revolving credit facility, and/or other financing sources. No shares were repurchased during the first quarter of 2026. As of March 31, 2026, the remaining authorization under the Repurchase Plan was $300 million.

We believe that our cash and cash equivalents on hand, our cash flows generated by our operations, amounts available under the revolving credit facility, the use of our factoring programs, and refinancing options available to us in the capital markets, will provide sufficient liquidity to operate our business, including the repayment of the current portion of our debt, for at least the next 12 months and for the foreseeable future thereafter.

For additional information regarding our cash requirements from lease obligations, indebtedness, and contractual obligations, see Note 4. “Leases,” Note 7. “Debt and Financing Arrangements,” and Note 14. “Commitments and Contingencies” in Part I, Item 1 of this Quarterly Report on Form 10-Q.

Financial Condition

The following table summarizes our asset and liability balances:

(In millions, except percentages)March 31, 2026December 31, 2025$ Change% Change
Current assets$3,211$3,288$(77)(2)%
Long-term assets8,9838,9749
Current liabilities3,7753,875(100)(3)%
Long-term liabilities5,4165,372441%

There were no material changes in our total assets and total liabilities from December 31, 2025, to March 31, 2026.

Cash Flow Activity

Our cash flows from operating, investing and financing activities, as reflected on our Condensed Consolidated Statements of Cash Flows, are summarized as follows:

(In millions, except percentages)Three Months Ended March 31, 2026Three Months Ended March 31, 2025Three Months Ended March 31,$ ChangeThree Months Ended March 31,% Change
Net cash provided by operating activities$31$29$27%
Net cash used in investing activities(62)(77)15(19)%
Net cash used in financing activities(26)(66)40(61)%
Effect of exchange rates on cash and cash equivalents(3)11(14)n/m
Net decrease in cash, restricted cash and cash equivalents$(60)$(103)$43(42)%

n/m - not meaningful

Operating Activities

Cash flows provided by operating activities for the three months ended March 31, 2026, increased by $2 million compared with the same period in 2025. The increase was due to higher net income adjusted for the net effect of non-cash items, offset by working capital consumption in 2026.

Investing Activities

Investing activities used $62 million and $77 million of cash for the three months ended March 31, 2026, and March 31, 2025, respectively. During the three months ended March 31, 2026, we utilized $65 million of cash to purchase property and equipment and received $3 million from the sale of property and equipment. During the three months ended March 31, 2025, we utilized $78 million of cash to purchase property and equipment and received $1 million from the sale of property and equipment.

Financing Activities

Financing activities used $26 million and $66 million of cash for the three months ended March 31, 2026, and March 31, 2025, respectively. The primary use of cash from financing activities during the three months ended March 31, 2026, was $15 million in payments for employee taxes on net settlement of equity awards and $14 million to repay finance lease obligations, partially offset by $7 million in proceeds from the exercise of stock options. The primary use of cash from financing activities during the three months ended March 31, 2025, was $106 million used to repurchase shares of our common stock pursuant to the Repurchase Plan, $11 million to repay finance lease obligations and $6 million in payments for employee taxes on net settlement of equity awards, partially offset by $56 million of net borrowings under revolving credit facilities.

Guaranteed Securities: Summarized Financial Information

The following information is provided to comply with Rule 13-01 of Regulation S-X under the Securities Exchange Act of 1934, as amended, for the €500 million 3.750% notes due 2030 issued by GXO Logistics Capital B.V. (“GXO Capital”), a subsidiary of the Company incorporated under the laws of the Netherlands. GXO Capital was incorporated in October 2025.

The €500 million 3.750% notes due 2030 are fully and unconditionally guaranteed on an unsecured and unsubordinated basis by GXO Logistics, Inc. (“GXO”). The €500 million 3.750% notes due 2030 are not guaranteed by any of GXO’s or GXO Capital’s subsidiaries (all GXO subsidiaries other than GXO Capital are referred to herein as "non-guarantor subsidiaries"). Holders of the €500 million 3.750% notes due 2030 will have a direct claim only against GXO Capital, as issuer, and GXO, as guarantor.

The following tables set forth the summarized financial information for the three months ended March 31, 2026, and as of March 31, 2026, and December 31, 2025, of GXO and GXO Capital, on a standalone basis, which does not include the consolidated impact of the assets, liabilities, and financial results of their subsidiaries except as noted in the tables below, nor does it include any impact of intercompany eliminations as there were no intercompany transactions between GXO and GXO Capital. This summarized financial information is not intended to present the financial position or results of operations of GXO or GXO Capital in accordance with U.S. generally accepted accounting principles (“GAAP”).

GXO

Summarized Results of Operations

Standalone and Unconsolidated (Unaudited)

(In millions)RevenueThree Months Ended · March 31, 2026$Three Months Ended · March 31, 2026
Costs and expenses6
Operating loss(6)
Other income from non-guarantor subsidiaries10
Other income, net3
Interest income from non-guarantor subsidiaries11
Interest expense, net(17)
Net income attributable to GXO standalone$1

GXO

Summarized Assets and Liabilities

Standalone and Unconsolidated (Unaudited)

(In millions)March 31, 2026December 31, 2025
Current assets$572$519
Investments in non-guarantor subsidiaries2,3612,361
Notes receivable from non-guarantor subsidiaries717860
Other noncurrent assets7781
Total assets$3,727$3,821
Accounts payable to non-guarantor subsidiaries$511$384
Current debt400400
Other current liabilities7993
Long-term debt1,7581,758
Notes payable to non-guarantor subsidiaries4210
Other noncurrent liabilities135167
Total liabilities$2,887$3,012

GXO Capital

Summarized Results of Operations

Standalone and Unconsolidated (Unaudited)

(In millions) · Revenue · Costs and expensesOperating incomeThree Months Ended · March 31, 2026 · $Three Months Ended · March 31, 2026
Interest expense, net(5)
Income tax benefit1
Loss attributable to GXO Capital standalone$(4)

GXO Capital

Summarized Assets and Liabilities

Standalone and Unconsolidated (Unaudited)

(In millions)March 31, 2026December 31, 2025
Current assets$2$3
Investments in non-guarantor subsidiaries2,3502,350
Other noncurrent assets1
Total assets$2,352$2,354
Current liabilities$8$6
Long-term debt571580
Total liabilities$579$586

Off-Balance Sheet Arrangements

We do not engage in any off-balance sheet financial arrangements that have or are reasonably likely to have a material current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

Contractual Obligations

As of March 31, 2026, the Company’s contractual obligations had not materially changed compared with December 31, 2025.

Critical Accounting Policies and Estimates

There have been no material changes to the critical accounting policies and estimates as previously disclosed in “Critical Accounting Policies” in Part II, Item 7 of our 2025 Form 10-K.

Accounting Pronouncements

Information related to new accounting standards is included in Note 1. “Basis of Presentation and Significant Accounting Policies and Estimates” in Part I, Item 1 of this Quarterly Report on Form 10-Q.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are exposed to market risk that may impact our Condensed Consolidated Financial Statements primarily due to variable-rate debt and fluctuations in certain foreign currencies. To reduce our exposure to market risk associated with interest and foreign currency exchange rate risks, we enter into various derivative instruments. There have been no material changes to our exposure to market risk for the three months ended March 31, 2026, from those previously disclosed in “Quantitative and Qualitative Disclosures About Market Risk” contained in Part II, Item 7A of our Form 10-K for the year ended December 31, 2025.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as such term is defined in Rule 13a-15(e) and Rule 15d-15(e) under the Securities Exchange Act of 1934, as amended, as of March 31, 2026. Based on that evaluation, our CEO and CFO concluded that our disclosure controls and procedures as of March 31, 2026, were effective as of such time such that the information required to be included in our Securities and Exchange Commission (“SEC”) reports is: (i) recorded, processed, summarized and reported within the time periods specified in SEC rules and forms relating to the Company, including our consolidated subsidiaries and (ii) accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act, during our most recently completed fiscal quarter that materially affected or are reasonably likely to materially affect our internal control over financial reporting.

PART II—OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

See Note 14. “Commitments and Contingencies” in Part I, Item 1 of this Quarterly Report on Form 10-Q for a description of our legal proceedings.

ITEM 1A. RISK FACTORS

There are no material changes to the risk factors as previously disclosed in “Risk Factors” contained in Part I, Item 1A of our Form 10-K for the year ended December 31, 2025.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities

None.

ITEM 6. EXHIBITS

Exhibit Number Description

10.1+ Employment contract between GXO Logistics Netherlands B.V. and Bart Beeks, dated as of February 12, 2026. (incorporated by reference to Exhibit 10.39 to the Company’s Annual Report on Form 10-K (Commission file no. 001-40470) filed with the SEC on February 25, 2026). 10.2+ Benefits Letter between GXO Logistics, Inc. and Bart Beeks, dated as of January 29, 2026. (incorporated by reference to Exhibit 10.40 to the Company’s Annual Report on Form 10-K (Commission file no. 001-40470) filed with the SEC on February 25, 2026). 10.3+ Offer letter between GXO Logistics, Inc. and Karen Bomber, dated as of January 15, 2026. (incorporated by reference to Exhibit 10.41 to the Company’s Annual Report on Form 10-K (Commission file no. 001-40470) filed with the SEC on February 25, 2026). 10.4+ Offer Letter, dated March 2, 2026, between Mark Suchinski and GXO Logistics, Inc. (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K (Commission file no. 001-40470) filed with the SEC on March 6, 2026). 10.5+ Settlement Agreement, dated as of February 20, 2026, by and between GXO Logistics UK Limited and Richard Cawston (incorporated by reference to Exhibit 10.34 to the Company’s Annual Report on Form 10-K (Commission file no. 001-40470) filed with the SEC on February 25, 2026). 10.6+ Offer Letter, dated January 29, 2026, between Laura Bracken and GXO Logistics, Inc. (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K (Commission file no. 001-40470) filed with the SEC on January 29, 2026). 10.7*+ Form of Restricted Stock Unit Award Agreement (2021 Omnibus Incentive Compensation Plan). 10.8*+ Form of Performance Share Unit Award Agreement (2021 Omnibus Incentive Compensation Plan). 31.1* Certification of the Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, with respect to the registrant’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2026. 31.2* Certification of the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, with respect to the registrant’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2026. 32.1** Certification of the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, with respect to the registrant’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2026. 32.2** Certification of the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, with respect to the registrant’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2026. 101.INS* Inline XBRL Instance Document. 101.SCH* Inline XBRL Taxonomy Extension Schema. 101.CAL* Inline XBRL Taxonomy Extension Calculation Linkbase. 101.DEF* Inline XBRL Taxonomy Extension Definition Linkbase. 101.LAB* Inline XBRL Taxonomy Extension Label Linkbase. 101.PRE* Inline XBRL Taxonomy Extension Presentation Linkbase. 104* Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).

  • Filed herewith. ** Furnished herewith.
  • This exhibit is a management contract or compensatory plan or arrangement.